Bajic, Z.; Sobot, T.; Amidzic, L.; Vojinovic, N.; Jovicic, S.; Gajic Bojic, M.; Djuric, D.M.; Stojiljkovic, M.P.; Bolevich, S.; Skrbic, R.
Liraglutide Protects Cardiomyocytes against Isoprenaline-Induced Apoptosis in Experimental Takotsubo Syndrome. Biomedicines 2024, 12, 1207.
https://doi.org/10.3390/biomedicines12061207
AMA Style
Bajic Z, Sobot T, Amidzic L, Vojinovic N, Jovicic S, Gajic Bojic M, Djuric DM, Stojiljkovic MP, Bolevich S, Skrbic R.
Liraglutide Protects Cardiomyocytes against Isoprenaline-Induced Apoptosis in Experimental Takotsubo Syndrome. Biomedicines. 2024; 12(6):1207.
https://doi.org/10.3390/biomedicines12061207
Chicago/Turabian Style
Bajic, Zorislava, Tanja Sobot, Ljiljana Amidzic, Natasa Vojinovic, Sanja Jovicic, Milica Gajic Bojic, Dragan M. Djuric, Milos P. Stojiljkovic, Sergey Bolevich, and Ranko Skrbic.
2024. "Liraglutide Protects Cardiomyocytes against Isoprenaline-Induced Apoptosis in Experimental Takotsubo Syndrome" Biomedicines 12, no. 6: 1207.
https://doi.org/10.3390/biomedicines12061207
APA Style
Bajic, Z., Sobot, T., Amidzic, L., Vojinovic, N., Jovicic, S., Gajic Bojic, M., Djuric, D. M., Stojiljkovic, M. P., Bolevich, S., & Skrbic, R.
(2024). Liraglutide Protects Cardiomyocytes against Isoprenaline-Induced Apoptosis in Experimental Takotsubo Syndrome. Biomedicines, 12(6), 1207.
https://doi.org/10.3390/biomedicines12061207
